August 25, 2016 3:20 PM ET

Pharmaceuticals

Company Overview of The Medicines Company

Executive Profile

John C. Kelly

Independent Director and Chairman of Audit Committee, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
73$420,310

Background

Mr. John C. Kelly served as a Vice President and Controller of Wyeth, LLC. Mr. Kelly served as Senior Vice President of Finance at Pfizer Inc. from October 2009 to February 2010. He served as Vice President of Finance Operations of Wyeth until March 2008. He joined Wyeth in 2002 and handled a wide range of assignments in finance. Mr. Kelly served as a Partner of Arthur Andersen LLP for more than 35 years. Mr. Kelly has over 40 years of experience in accounting and finance, ...

Corporate Headquarters

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships

2009-Present
Independent Director, Chairman of Audit Committee and Member of Finance Committee
2011-Present
Independent Director and Chairman of Audit Committee

Education

BS
Seton Hall University
MBA
Seton Hall University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$111,417
Total Calculated Compensation$420,310
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
$1.0M
Ian R. Garland Chief Executive Officer, Executive Director and Member of Nominations & Corporate Governance Committee
Vernalis plc
$991.0K
John Dawson Chief Executive Officer and Executive Director
Oxford BioMedica PLC
$511.0K
Ronald M. Lombardi Chief Executive Officer, President, Interim Chief Financial Officer and Director
Prestige Brands Holdings, Inc.
$735.5K
Rick E. Winningham Chairman, Chief Executive Officer and Member of Science & Technology Committee
Theravance Biopharma, Inc.
$902.1K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Medicines Company, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.